Outcomes in anterior uveitis associated with the HLA-B27 haplotype

Ophthalmology

Volumn 105, Issue 9, 1998, Pages 1646-1651

  Power, William J ^a,b   Rodriguez, Alejandro ^a   Pedroza Seres, Miguel ^a   Foster, C Stephen ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA B27 ANTIGEN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CORTICOSTEROID THERAPY; FEMALE; HAPLOTYPE; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEROCONVERSION; TOPICAL DRUG ADMINISTRATION; VISUAL ACUITY;

EID: 0031793309     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)99033-9     Document Type: Article

References (20)

1. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996;114:593-9.
2. Smit RLMJ, Baarsma GS, deVries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol 1993;17:71-6.
3. Weiner A, BenEzra D. Clinical patterns and associated conditions in chronic uveitis. Am J Ophthalmol 1991;112:151-8.
4. Brewerton DA, Caffrey M, Nicholls A, et al. Acute anterior uveitis and HL-A 27. Lancet 1973;2:994-6.
5. Mapstone R, Woodrow JC. HL-A 27 and acute anterior uveitis. Br J Ophthalmol 1975;59:270-5.
6. Wakefield D, Montanaro A, McCluskey P. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 1991;36:223-32.
7. Rothova A, Kijlstra A, Buitenhuis HJ, et al. HLA-B27 associated uveitis - a distinct clinical entity? In: Saari KM, ed. Uveitis update: Proceedings of the First Int'l Symposium on Uveitis, Hanasaar, Espoa, Finland, May 16-19, 1984. Amsterdam; New York: Excerpta Medica; New York, NY: Sale distributors for the Asia and Canada, Elsevier Science Pub. Co., 1984;91-5.
8. Wakefield D, Easter J, Penny R. Clinical features of HLA-B27 anterior uveitis. Aust J Ophthalmol 1984;12:191-6.
9. Rothova A, van Veenendaal WG, Linssen A, et al. Clinical features of acute anterior uveitis. Am J Ophthalmol 1987;103: 137-45.
10. Beckingsale AB, Guss RB, Rosenthal AR. Acute anterior uveitis associated with HLA B27 positive tissue type. A comparative study in two populations. Trans Ophthalmol Soc UK 1982;102:168-70.
11. Dougados M, van der Linden SJEF, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
12. Lee DA, Barker SM, Daniel Su WP, et al. The clinical diagnosis of Reiter's syndrome. Ophthalmic and nonophthalmic aspects. Ophthalmology 1986;93:350-6.
13. Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology 1994;101:1267-74.
14. Brewerton DA, Hart FD, Nicholls A, et al. Ankylosing Spondylitis and HL-A 27. Lancet 1973;1:904-7.
15. Khan MA, Kushner I, Braun WE. Association of HLA-A2 with uveitis in HLA-B27 positive patients with ankylosing spondylitis. J Rheumatol 1981;8:295-8.
16. D'Alessandro LP, Forster DJ, Rao NA. Anterior uveitis and hypopyon. Am J Ophthalmol 1991;112:317-21.
17. Rodriguez A, Power WJ, Neves RA, Foster CS. Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir. Doc Ophthalmol 1995;90:331-40.
18. Faris BM, Foster CS. Behcet's Disease. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology: Clinical Practice. Philadelphia: WB Saunders, 1994; v. 2, chap. 88.
19. Tamesis RR, Foster CS. Ocular Syphilis. Ophthalmology 1990;97:1281-7.
20. Linssen A, Meenken C. Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis. Am J Ophthalmol 1995;120:351-61.